Sanofi and GSK to provide 72 million vaccine doses to Canada The vaccine candidate is based on technology that Sanofi has used to produce seasonal influenza vaccines and on immunological agents developed by GSK. Published 23 Sep, 2020 02:40am
Sanofi, GSK to supply up to 60 million doses of COVID-19 vaccine to UK The first clinical trials are expected in September. Updated 29 Jul, 2020 12:59pm
World COVID-19 prompts increased focus on self-care, with Europeans taking their health more seriously to relieve pressure on healthcare systems significant proportion of Europeans are now taking extra precautions to avoid illness-transmission: Spain 80 %, Italy 79 %, UK 68 %, Germany 60 % Updated 23 Jul, 2020 01:44pm
Business & Finance GSK to develop plant-based COVID-19 vaccine with Canada's Medicago Rather than developing its own vaccine in the global race to combat the pandemic, GSK has instead focused on contributing its adjuvant technology to at least seven other global companies. Published 08 Jul, 2020 10:44am
World Sanofi eyes approval of COVID-19 vaccine by first half of 2021 The probability of success for Sanofi is "higher than anybody else," the CEO said. Published 23 Jun, 2020 11:43am